Evidence map›Paper›PMID 26410426›Full record

ArticleWorld journal of microbiology & biotechnology2015

Continuing hunt for endophytic actinomycetes as a source of novel biologically active metabolites.

Meeta Masand, Polpass Arul Jose, Ekta Menghani, Solomon Robinson David Jebakumar

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Frontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Marine drugs · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Endophytic actinomycetes Streptomyces spp mediated biosynthesis of copper oxide nanoparticles as a promising tool for biotechnological applications.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2019
    Article
  10. Article
  11. Endophytic Actinomycetes from Tea Plants (BioMed research international · 2018
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meeta MasandSchool of Life sciences, Suresh Gyan Vihar University, Jaipur, India.
Polpass Arul JoseDepartment of Molecular Microbiology, School of Biotechnology, Madurai Kamaraj University, Madurai, India. arulmku@gmail.com.
Ekta MenghaniDepartment of Biotechnology, School of Science, JECRC University, Jaipur, India.
Solomon Robinson David JebakumarDepartment of Molecular Microbiology, School of Biotechnology, Madurai Kamaraj University, Madurai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-resistant pathogens and persistent agrochemicals mount the detrimental threats against human health and welfare. Exploitation of beneficial microorganisms and their metabolic inventions is most promising way to tackle these two problems. Since the successive discoveries of penicillin and streptomycin in 1940s, numerous biologically active metabolites have been discovered from different microorganisms, especially actinomycetes. In recent years, actinomycetes that inhabit unexplored environments have received significant attention due to their broad diversity and distinctive metabolic potential with medical, agricultural and industrial importance. In this scenario, endophytic actinomycetes that inhabit living tissues of plants are emerging as a potential source of novel bioactive compounds for the discovery of drug leads. Also, endophytic actinomycetes are considered as bio-inoculants to improve crop performance through organic farming practices. Further efforts on exploring the endophytic actinomycetes associated with the plants warrant the likelihood of discovering new taxa and their metabolites with novel chemical structures and biotechnological importance. This mini-review highlights the recent achievements in isolation of endophytic actinomycetes and an assortment of bioactive compounds.

Indexed as

ActinobacteriaBiological ProductsBiotechnologyDrug DiscoveryEndophytesHumansPlantsBiological ProductsActinomycetesBioactive compoundsDrug discoveryEndophytes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.